Stocks are on a tear on hopes for treatments and vaccines that can help end the current public-health crisis, but fears that equity-market valuations on Wall Street have gotten rich and well ahead of themselves continue to trouble many within the investment community.
Stocks are on a tear on hopes for treatments and vaccines that can help end the current public-health crisis, but fears that equity-market valuations on Wall Street have gotten rich and well ahead of themselves continue to trouble many within the investment community.